Hypolipemic effect of water extracts of Picrorrhiza rhizoma in PX-407 induced hyperlipemic ICR mouse model with hepatoprotective effects: A prevention study

Journal of Ethnopharmacology

Volumn 105, Issue 3, 2006, Pages 380-386

  Lee, Hyeung Sik ^a   Ahn, Hyo Chan ^a   Ku, Sae Kwang ^b  

^a Daegu Haany University   (South Korea)

^b DongWha Pharm Ind Co   (South Korea)

Author keywords

Hepatoprotective; Hyperlipemia; Picrorrhiza rhizoma

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PICRORRHIZA RHIZOMA EXTRACT; PLANT EXTRACT; POLOXAMER; SIMVASTATIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; WATER;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE REGIMEN; DRUG EFFECT; HYPERLIPIDEMIA; HYPOLIPEMIA; LIPOPROTEIN BLOOD LEVEL; LIVER PROTECTION; LIVER WEIGHT; MALE; MEDICINAL PLANT; MONITORING; MOUSE; MOUSE STRAIN; NONHUMAN; PICRORRHIZA RHIZOMA; STATISTICAL SIGNIFICANCE; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT CHANGE; WEIGHT GAIN;

ALANINE TRANSAMINASE; ANIMALS; ANTILIPEMIC AGENTS; ASPARTATE AMINOTRANSFERASES; BODY WEIGHT; CHOLESTEROL; HYPERLIPIDEMIAS; HYPOLIPIDEMIC AGENTS; LIVER; MALE; MICE; MICE, INBRED ICR; ORGAN SIZE; PHYTOTHERAPY; PICRORHIZA; PLANT EXTRACTS; SIMVASTATIN; TRIGLYCERIDES;

EID: 33748713253     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2005.11.010     Document Type: Article

References (37)

1. Bhandari U., Kanojia R., and Pillai K.K. Effect of ethanolic extract of Embelia ribes on dyslipidemia in diabetic rats. International Journal of Experimental Diabetes Research 3 (2002) 159-162
2. Ble-Castillo J.L., Rodriguez-Hernandez A., Miranda-Zamora R., Juarez-Oropeza M.A., and Diaz-Zagoya J.C. Arthrospira maxima prevents the acute fatty liver induced by the administration of simvastatin, ethanol and a hypercholesterolemic diet to mice. Life Sciences 70 (2002) 2665-2673
3. Cheng J.W. Rosuvastatin in the management of hyperlipidemia. Clinical Therapeutics 26 (2004) 1368-1387
4. el-Saadany S.S., el-Massry R.A., Labib S.M., and Sitohy M.Z. The biochemical role and hypocholesterolaemic potential of the legume Cassia fistula in hypercholesterolaemic rats. Die Nahrung 35 (1991) 807-815
5. Forrester J.S., Makkar R., and Shah P.K. Increasing high-density lipoprotein cholesterol in dyslipidemia by cholesteryl ester transfer protein inhibition: an update for clinicians. Circulation 111 (2005) 1847-1854
6. Grundy S.M. Cholesterol and coronary heart disease: a new era. Journal of the American Medical Association 256 (1986) 2849-2858
7. Han L.K., Zheng Y.N., Yoshikawa M., Okuda H., and Kimura Y. Anti-obesity effects of chikusetsusaponins isolated from Panax japonicus rhizomes. BMC Complementary and Alternative Medicine 5 (2005) 9
8. Hoyos M., Guerrero J.M., Perez-Cano R., Olivan J., Fabiani F., Garcia-Perganeda A., and Osuna C. Serum cholesterol and lipid peroxidation are decreased by melatonin in diet-induced hypercholesterolemic rats. Journal of Pineal Research 28 (2000) 150-155
9. Jagetia G.C., and Baliga M.S. The evaluation of nitric oxide scavenging activity of certain Indian medicinal plants in vitro: a preliminary study. Journal of Medicinal Food 7 (2004) 343-348
10. Jeena K.J., Joy K.L., and Kuttan R. Effect of Emblica officinalis Phyllanthus amarus and Picrorrhiza kurroa on N-nitrosodiethylamine induced hepatocarcinogenesis. Cancer Letters 136 (1999) 11-16
11. Johnston T.P. The P-407-induced murine model of dose-controlled hyperlipidemia and atherosclerosis: a review of findings to date. Journal of Cardiovascular Pharmacology 43 (2004) 595-606
12. Johnston T.P., Baker J.C., Jamal A.S., Hall D., Emeson E.E., and Palmer W.K. Potential downregulation of HMG-CoA reductase after prolonged administration of P-407 in C57BL/6 mice. Journal of Cardiovascular Pharmacology 34 (1999) 831-842
13. Johnston T.P., Coker J.W., Paigen B.J., and Tawfik O. Sex does not seem to influence the formation of aortic lesions in the P-407-induced mouse model of hyperlipidemia and atherosclerosis. Journal of Cardiovascular Pharmacology 39 (2002) 404-411
14. Johnston T.P., Nguyen L.B., Chu W.A., and Shefer S. Potency of select statin drugs in a new mouse model of hyperlipidemia and atherosclerosis. International Journal of Pharmaceutics 229 (2001) 75-86
15. Johnston T.P., and Palmer W.K. Mechanism of poloxamer 407-induced hypertriglyceridemia in the rat. Biochemical Pharmacology 46 (1993) 1037-1042
16. Joy K.L., and Kuttan R. Anti-diabetic activity of Picrorrhiza kurroa extract. Journal of Ethnopharmacology 67 (1999) 143-148
17. Joy K.L., Rajeshkumar N.V., Kuttan G., and Kuttan R. Effect of Picrorrhiza kurroa extract on transplanted tumours and chemical carcinogenesis in mice. Journal of Ethnopharmacology 71 (2000) 261-266
18. Kamada T., Hata J., Kusunoki H., Ito M., Tanaka S., Kawamura Y., Chayama K., and Haruma K. Eradication of Helicobacter pylori increases the incidence of hyperlipidaemia and obesity in peptic ulcer patients. Digestive and Liver Disease 37 (2005) 39-43
19. Lal J.J., Sreeranjit Kumar C.V., Suresh M.V., Indira M., and Vijayammal P.L. Effect of in utero exposure of toddy (coconut palm wine) on liver function and lipid metabolism in rat fetuses. Plant Foods for Human Nutrition 52 (1998) 209-219
20. Le P.M., Benhaddou-Andaloussi A., Elimadi A., Settaf A., Cherrah Y., and Haddad P.S. The petroleum ether extract of Nigella sativa exerts lipid-lowering and insulin-sensitizing actions in the rat. Journal of Ethnopharmacology 94 (2004) 251-259
21. Levy C., Seeff L.D., and Lindor K.D. Use of herbal supplements for chronic liver disease. Clinical Gastroenterology and Hepatology 2 (2004) 947-956
22. Mehrotra R., Rawat S., Kulshreshtha D.K., Patnaik G.K., and Dhawan B.N. In vitro studies on the effect of certain natural products against hepatitis B virus. The Indian Journal of Medical Research 92 (1990) 133-138
23. Milionis H.J., Kakafika A.I., Tsouli S.G., Athyros V.G., Bairaktari E.T., Seferiadis K.I., and Elisaf M.S. Effects of statin treatment on uric acid homeostasis in patients with primary hyperlipidemia. American Heart Journal 148 (2004) 635-640
24. Morishita S., Saito T., Mishima Y., Mizutani A., Hirai Y., Koyama S., and Kawakami M. Strains and species differences in experimental hyperlipidemia. Nippon Yakugaku Zasshi 87 (1986) 259-264
25. Mukai M., Ozasa K., Hayashi K., and Kawai K. Various S-GOT/S-GPT ratios in nonviral liver disorders and related physical conditions and life-style. Digestive Diseases and Sciences 47 (2002) 549-555
26. Neaton J.D., Kuller L.H., Wentworth D., and Borhani N.O. Total and cardiovascular mortality in relation to cigarette smoking, serum cholesterol concentration and diastolic blood pressure among black and white males followed up for five years. American Heart Journal 108 (1984) 759-769
27. Olsson B., Bohlooly-Y M., Fitzgerald S.M., Frick F., Ljungberg A., Ahren B., Tornell J., Bergstrom G., and Oscarsson J. Bovine growth hormone transgenic mice are resistant to diet-induced obesity but develop hyperphagia, dyslipidemia, and diabetes on a high-fat diet. Endocrinology 146 (2005) 920-930
28. Palmer W.K., Emeson E.E., and Johnston T.P. The poloxamer 407-induced hyperlipidemic atherogenic animal model. Medicine and Science in Sports and Exercise 29 (1997) 1416-1421
29. Park K.J., Kim H.Y., Chang B.J., and Lee H.H. Ameliorative effects of soy 11S protein on liver damage and hyperlipidemia in alcohol-fed rats. Biological & Pharmaceutical Bulletin 27 (2004) 1636-1641
30. Pirat B., Korkmaz M.E., Eroglu S., Tayfun E., Yildirir A., Ulucam M., Ozin B., and Muderrisoglu H. The effects of simvastatin combined with different antioxidant vitamin regimens on serum lipid profile in patients with low HDL cholesterol levels. Anadolu Kardiyoloji Dergisi 4 (2004) 318-322
31. Senthil Kumar S.H., Anandan R., Devaki T., and Santhosh Kumar M. Cardioprotective effects of Picrorrhiza kurroa against isoproterenol-induced myocardial stress in rats. Fitoterapia 72 (2001) 402-405
32. Steinmetz E.F., Buckley C., Shames M.L., Ennis T.L., Vanvickle-Chavez S.J., Mao D., Goeddel L.A., Hawkins C.J., and Thompson R.W. Treatment with simvastatin suppresses the development of experimental abdominal aortic aneurysms in normal and hypercholesterolemic mice. Annals of Surgery 41 (2005) 92-101
33. Tan B.K., Tan C.H., and Pushparaj P.N. Anti-diabetic activity of the semi-purified fractions of Averrhoa bilimbi in high fat diet fed-streptozotocin-induced diabetic rats. Life Sciences 76 (2005) 2827-2839
34. Vickers S., Duncan C.A., Vyas K.P., Kari P.H., Arison B., Prakash S.R., Ramjit H.G., Pitzenberger S.M., Stokker G., and Duggan D.E. In vitro and in vivo biotransformation of simvastatin, an inhibitor of HMG CoA reductase. Drug Metabolism and Disposition 18 (1990) 476-483
35. Wasan K.M., Subramanian R., Kwong M., Goldberg I.J., Wright T., and Johnston T.P. Poloxamer 407-mediated alterations in the activities of enzymes regulating lipid metabolism in rats. Journal of Pharmacy & Pharmaceutical Sciences 6 (2003) 189-197
36. Yamashita J., and Hayashi S. The effect of dietary protein source on plasma cholesterol level and fecal steroid excretion in obese mice. Journal of Nutritional Science and Vitaminology 36 (1990) 545-558
37. Zdrenghea D., Gligor E., Ossian V., and Pop D. The effect of simvastatin associated with ranitidine and alcohol upon serum lipids. Romanian Journal of Internal Medicine 42 (2004) 143-148